Tag: Frank Mathias
Rentschler expands cGMP manufacturing capacity
Rentschler Biotechnologie GmbH, a contract development and manufacturing organization (CDMO) for biopharmaceuticals, has recently opened a new single-use bioreactor at the Company’s site in Laupheim with a capacity of 2,000 liters.